Michael Gelband’s CyrusOne Inc Common Stock CONE Stock Holding History

Michael Gelband’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23,922	Closed	-$2.15M	–	2859
2021 Q4	$2.15M	Buy	+23,922	New	+$2.03M	0.02%	729
2020 Q4	–	Sell	-21,225	Closed	-$1.49M	–	2536
2020 Q3	$1.49M	Sell	21,225 -67,892	-76%	-$5.32M	0.03%	511
2020 Q2	$6.48M	Buy	89,117 +49,253	+124%	+$3.51M	0.17%	114
2020 Q1	$2.46M	Buy	39,864 +34,760	+681%	+$2.12M	0.14%	153
2019 Q4	$334K	Buy	+5,104	New	+$350K	0.01%	1095
2019 Q3	–	Sell	-14,680	Closed	-$847K	–	1740
2019 Q2	$847K	Buy	+14,680	New	+$860K	0.03%	305

Other funds holding CONE

JCM

Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return

Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Michael Gelband's CONE Position: Q1 2022 in Review

Michael Gelband sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 23,922 shares — an estimated $2.15M sold.

Michael Gelband first reported a position in CONE in Q2 2019 and held it in 6 quarters. The position peaked at $6.48M in Q2 2020. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

Michael Gelband reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
Michael Gelband sold 23,922 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $2.15M.
Michael Gelband first reported a position in CyrusOne Inc Common Stock in Q2 2019 and held it in 6 quarters.
Michael Gelband's CyrusOne Inc Common Stock position peaked at $6.48M in Q2 2020.
3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.